Skip to main content
. 2018 Apr 9;40(1):73–76. doi: 10.1590/1678-4685-JBN-3743

Table 1. Characteristics of the patients.

Number of participants 72
Age (years) 50 [40; 63]
Male 40 (56.3)
Diagnosis  
CKD 60 (83)
Candidate for living kidney donation 12 (17)
Weight (kg) 72.0 [60.5; 90.0]
Height (cm) 168.0 [160.0; 174.5]
Body surface area (m2) 1.83 [1.63; 2.01]
Body mass index (kg/m2) 25.3 [22.3; 32.0]
mGFR (mL/min/1.73 m2) (n = 62) 74.5 [53.0; 91.0]
eGFR (mL/min/1.73 m2) 70.0 [39.0; 96.0]
mean mGFR-eGFR (95%CI), mL/min/1.73 m2 (N = 62) -3.8 (-7.0; -0.5)
Plasma oxalate  
Plasma oxalate < 5 µmol/L 67 (93.0)
Plasma oxalate ≥ 5 µmol/L 5 (7.0)
CKD stages  
Stage I 16 (22.2)
Stage II 28 (38.9)
Stage IIIa 4 (5.5)
Stage IIIb 10 (13.9)
Stage IV 11 (15.3)
Stage V 3 (4.0)

Values are median (IQR) or n (%) unless otherwise specified CKD: chronic kidney disease; GFR: glomerular filtration rate; IQR: interquartile range. CKD stages were determined according to mGFR or eGFR if not available.